# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-23-019369
Filing Date
2023-11-29
Accepted
2023-11-28 21:20:41
Documents
95
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | cycc-20221231x10ka.htm iXBRL | 10-K/A | 3346581
2 | EX-4.10 | cycc-20221231xex4d10.htm | EX-4.10 | 172913
3 | EX-10.16 | cycc-20221231xex10d16.htm | EX-10.16 | 50624
4 | EX-23.1 | cycc-20221231xex23d1.htm | EX-23.1 | 2672
5 | EX-31.1 | cycc-20221231xex31d1.htm | EX-31.1 | 12937
6 | EX-31.2 | cycc-20221231xex31d2.htm | EX-31.2 | 12691
7 | EX-32.1 | cycc-20221231xex32d1.htm | EX-32.1 | 6411
8 | EX-32.2 | cycc-20221231xex32d2.htm | EX-32.2 | 6480
| Complete submission text file | 0001558370-23-019369.txt |  | 15275969

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | cycc-20221231.xsd | EX-101.SCH | 66462
10 | EX-101.CAL | cycc-20221231_cal.xml | EX-101.CAL | 56609
11 | EX-101.DEF | cycc-20221231_def.xml | EX-101.DEF | 356251
12 | EX-101.LAB | cycc-20221231_lab.xml | EX-101.LAB | 474089
13 | EX-101.PRE | cycc-20221231_pre.xml | EX-101.PRE | 525717
89 | EXTRACTED XBRL INSTANCE DOCUMENT | cycc-20221231x10ka_htm.xml | XML | 3714799

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50626 | Film No.: 231448220
SIC: 2834 Pharmaceutical Preparations